Task: Answer the multiple choice question.
Query: Which drug exhibits a 17.125% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. CC(C)Sc1n[nH]c(=O)n1-c1cccc(C(F)(F)F)c1
b. Cc1ccc(S(=O)(=O)N(Cc2cc3cccc(C)c3[nH]c2=O)c2ccccc2)cc1
Answer: a. CC(C)Sc1n[nH]c(=O)n1-c1cccc(C(F)(F)F)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)Sc1n[nH]c(=O)n1-c1cccc(C(F)(F)F)c1
CC(C)Sc1n[nH]c(=O)n1-c1cccc(C(F)(F)F)c1
3-propan-2-ylsulfanyl-4-[3-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-5-one